Expertise in
5
conditions

Kiran V. Godse

Mumbai, MH, IN 
Expertise in
5
conditions
Mumbai, MH, IN 
OverviewLocationsClinical Research

Overview

Kiran Godse practices in Mumbai, India. Godse is highly rated in 5 conditions, according to our data. Their top areas of expertise are Chronic Spontaneous Urticaria (CSU), Hives, Melasma, and Angioedema.

Their clinical research consists of co-authoring 106 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years.

Locations

Mumbai, MH, India
Other Locations
Navi Mumbai, MH, India
Kolkata, WB, India
Venereology and Leprosy Dr. Ram Manohar Lohia Hospital and Post Graduate Institute of Medical Education and Research
New Delhi, DL, India

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A Phase 3 Multicenter, Double-Blind Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Adult Patients With Atopic Dermatitis
A Phase 3 Multicenter, Double-Blind Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Adult Patients With Atopic Dermatitis
Enrollment Status: Completed
Publish Date: September 03, 2024
Intervention Type: Drug
Study Drug: Baricitinib
Study Phase: Phase 3
A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Dose-Ranging Trial to Evaluate the Efficacy and Safety of ASLAN004 in Adult Patients With Moderate-to-Severe Atopic Dermatitis
A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Dose-Ranging Trial to Evaluate the Efficacy and Safety of ASLAN004 in Adult Patients With Moderate-to-Severe Atopic Dermatitis
Enrollment Status: Completed
Publish Date: April 26, 2024
Intervention Type: Drug, Biological
Study Drug: ASLAN004
Study Phase: Phase 2
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib in Adult Patients With Moderate to Severe Atopic Dermatitis
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib in Adult Patients With Moderate to Severe Atopic Dermatitis
Enrollment Status: Completed
Publish Date: August 18, 2020
Intervention Type: Drug
Study Phase: Phase 3
View 2 Less Clinical Trials

106 Total Publications

Efficacy of Vitamin D3 Supplementation as an Adjunct to Bilastine 40 mg in Chronic Spontaneous Urticaria Patients With Vitamin D3 Deficiency: A Randomized, Double-Blind, Placebo-Controlled Study.
Efficacy of Vitamin D3 Supplementation as an Adjunct to Bilastine 40 mg in Chronic Spontaneous Urticaria Patients With Vitamin D3 Deficiency: A Randomized, Double-Blind, Placebo-Controlled Study.
Journal: International journal of dermatology
Published: May 04, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Godse's expertise for a condition
ConditionClose
View All 21 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile